| Product NDC: | 10597-559 |
| Proprietary Name: | Fasprin |
| Non Proprietary Name: | Aspirin |
| Active Ingredient(s): | 81 mg/1 & nbsp; Aspirin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 10597-559 |
| Labeler Name: | Nobel Laboratories, LLC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part343 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20060920 |
| Package NDC: | 10597-559-05 |
| Package Description: | 30 TABLET, ORALLY DISINTEGRATING in 1 BOX (10597-559-05) |
| NDC Code | 10597-559-05 |
| Proprietary Name | Fasprin |
| Package Description | 30 TABLET, ORALLY DISINTEGRATING in 1 BOX (10597-559-05) |
| Product NDC | 10597-559 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Aspirin |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20060920 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Nobel Laboratories, LLC |
| Substance Name | ASPIRIN |
| Strength Number | 81 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |